Bausch Stock Analysis

BHC
 Stock
  

USD 6.01  0.19  3.06%   

The big decline in price over the last few months for Bausch Health Companies could raise concerns from investors as the firm is trading at a share price of 6.01 on 6,587,400 in volume. The company management teams failed to add value to investors and position the firm supply of money to exploit market volatility in July. However, diversifying your holdings with Bausch Health Companies or similar stocks can still protect your portfolios during high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 7.45. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the Bausch Health partners.
Continue to Trending Equities.
  
The Bausch Health stock analysis report makes it easy to digest most publicly released information about Bausch Health and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Bausch Stock analysis module also helps to analyze the Bausch Health price relationship with some important fundamental indicators such as market cap and management efficiency.

Bausch Stock Analysis Notes

About 73.0% of the company shares are held by institutions such as insurance companies. The company has Price/Earnings To Growth (PEG) ratio of 0.09. Bausch Health Companies recorded a loss per share of 3.27. The entity last dividend was issued on the 10th of November 2010. The firm had a split on the 16th of October 2000. Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. Bausch Health Companies Inc. is headquartered in Laval, Canada. Bausch Health operates under Drug Manufacturers - Specialty Generic classification in the United States and is traded on New York Stock Exchange. It employs 19600 people. For more info on Bausch Health Companies please contact Joseph Papa at 514-744-6792 or go to https://www.bauschhealth.com.

Bausch Health Quarterly Cost of Revenue

577 Million

Bausch Health Companies Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Bausch Health's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Bausch Health Companies or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Bausch Health generated a negative expected return over the last 90 days
Bausch Health has high historical volatility and very poor performance
Bausch Health has high likelihood to experience some financial distress in the next 2 years
The company reported the last year's revenue of 8.33 B. Reported Net Loss for the year was (407 M) with profit before taxes, overhead, and interest of 6.04 B.
About 73.0% of the company shares are held by institutions such as insurance companies
Latest headline from www.marketscreener.com: RBC Capital Reviews Bausch Healths Q2, Trims Target to US4.50 - Marketscreener.com

Bausch Health Companies Upcoming and Recent Events

Earnings reports are used by Bausch Health to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Bausch Health previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report23rd of February 2022
Next Financial Report3rd of May 2022
Next Fiscal Quarter End31st of December 2021
Next Fiscal Year End23rd of February 2022
Last Quarter Report30th of September 2021
Last Financial Announcement31st of December 2020

Bausch Largest EPS Surprises

Earnings surprises can significantly impact Bausch Health's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
1997-02-27
1996-12-310.060.070.0116 
2001-04-26
2001-03-310.180.20.0211 
1996-07-17
1996-06-300.040.060.0250 
View All Earnings Estimates

Bausch Health SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Bausch Health prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Bausch Health investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Bausch Health Companies specific information freely available to individual and institutional investors to make a timely investment decision.
29th of July 2022
Financial Statements and Exhibits. Other Events
View
20th of July 2022
Regulation FD Disclosure
View
23rd of June 2022
Financial Statements and Exhibits. Submission of Matters to a Vote of Security Holders. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
View
21st of June 2022
Financial Statements and Exhibits. Regulation FD Disclosure
View
3rd of June 2022
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
View
31st of May 2022
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
View
12th of May 2022
Unclassified Corporate Event
View
10th of May 2022
Financial Statements and Exhibits. Other Events. Results of Operations and Financial Condition. Entry into a Material Definitive Agreement
View

Bausch Health Thematic Classifications

In addition to having Bausch Health stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Pharmaceutical Products
USA Equities from Pharmaceutical Products industry as classified by Fama & French

Bausch Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Bausch Health is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Bausch Health Companies backward and forwards among themselves. Bausch Health's institutional investor refers to the entity that pools money to purchase Bausch Health's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Vanguard Group IncCommon Shares10.7 M89.5 M
Franklin Resources IncCommon Shares7.4 M61.6 M
Segantii Capital Management LtdCommon Shares5.7 M47.7 M
Kohlberg Kravis Roberts Co LpCommon Shares5.2 M43.8 M
Fiera Capital CorpCommon Shares3.4 M28.8 M
Jpmorgan Chase CoCommon Shares2.9 M24.2 M
Bank Of MontrealCommon Shares2.5 M21.7 M
Group One Trading LpCall Options1.3 M10.9 M
Bank Of America CorpPut Options1.3 M10.9 M
Note, although Bausch Health's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Bausch Market Capitalization

The company currently falls under 'Mid-Cap' category with total capitalization of 2.08 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Bausch Health's market, we take the total number of its shares issued and multiply it by Bausch Health's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Bausch Profitablity

Bausch Health's profitability indicators refer to fundamental financial ratios that showcase Bausch Health's ability to generate income relative to its revenue or operating costs. If, let's say, Bausch Health is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Bausch Health's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Bausch Health's profitability requires more research than a typical breakdown of Bausch Health's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Net Profit Margin of (4.89) %, which means that it does not effectively control expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of 19.72 %, which entails that for every 100 dollars of revenue, it generated 0.2 of operating income.
Last ReportedProjected for 2022
Return on Average Assets(0.032) (0.0345) 
Return on Average Equity 3.18  3.42 
Return on Invested Capital 0.015  0.012 
Return on Sales 0.046  0.0496 

Management Efficiency

The entity has Return on Asset of 3.46 % which means that on every $100 spent on asset, it made $3.46 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of (328.2) %, meaning that it generated no profit with money invested by stockholders. Bausch Health management efficiency ratios could be used to measure how well bausch health companies manages its routine affairs as well as how well it operates its assets and liabilities. Bausch Health Return on Average Equity is projected to increase slightly based on the last few years of reporting. The past year's Return on Average Equity was at 3.18. The current year Return on Sales is expected to grow to 0.0496, whereas Return on Average Assets are forecasted to decline to (0.0345) . Bausch Health Total Assets are projected to increase significantly based on the last few years of reporting. The past year's Total Assets were at 29.2 Billion. The current year Assets Non Current is expected to grow to about 27.8 B, whereas Current Assets are forecasted to decline to about 5.6 B.
Last ReportedProjected for 2022
Book Value per Share(0.29) (0.30) 
Enterprise Value over EBIT 78.00  62.22 
Enterprise Value over EBITDA 15.63  22.69 
Price to Book Value(93.59) (96.06) 
Tangible Assets Book Value per Share 27.30  26.09 
Enterprise Value30.4 B32.1 B
Tangible Asset Value9.8 B9.2 B

Technical Drivers

As of the 14th of August 2022, Bausch Health shows the mean deviation of 4.4, and Risk Adjusted Performance of (0.05). Bausch Health Companies technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Put another way, you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum, or the prices will eventually revert. We have analyze and collected data for nineteen technical drivers for Bausch Health Companies, which can be compared to its rivals. Please confirm Bausch Health Companies jensen alpha, potential upside, skewness, as well as the relationship between the maximum drawdown and semi variance to decide if Bausch Health Companies is priced correctly, providing market reflects its regular price of 6.01 per share. Given that Bausch Health has jensen alpha of (0.48), we suggest you to validate Bausch Health Companies's prevailing market performance to make sure the company can sustain itself at a future point.

Bausch Health Companies Price Movement Analysis

Illegal number of arguments. The output start index for this execution was zero with a total number of output elements of zero. The Weighted Moving Average calculates a weight for each value in Bausch Health price series with the more recent values given greater weights.
.

Bausch Health Companies Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Bausch Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on Bausch Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Bausch Health insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Bausch Health Predictive Daily Indicators

Bausch Health intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Bausch Health stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Bausch Health Forecast Models

Bausch Health time-series forecasting models is one of many Bausch Health's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Bausch Health's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Bausch Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Bausch Health stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Bausch shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Bausch Health. By using and applying Bausch Stock analysis, traders can create a robust methodology for identifying Bausch entry and exit points for their positions.
Last ReportedProjected for 2022
EBITDA Margin 0.23  0.24 
Gross Margin 0.72  0.79 
Profit Margin(0.11) (0.12) 
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. Bausch Health Companies Inc. is headquartered in Laval, Canada. Bausch Health operates under Drug Manufacturers - Specialty Generic classification in the United States and is traded on New York Stock Exchange. It employs 19600 people.

Current Bausch Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Bausch analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Bausch analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
40.14Buy7Odds
Bausch Health Companies current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Bausch analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Bausch stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Bausch Health Companies, talking to its executives and customers, or listening to Bausch conference calls.
Bausch Analyst Advice Details

Bausch Stock Analysis Indicators

Bausch Health Companies stock analysis indicators help investors evaluate how Bausch Health stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Bausch Health shares will generate the highest return on investment. By understating and applying Bausch Health stock analysis, traders can identify Bausch Health position entry and exit signals to maximize returns.
Quick Ratio0.59
Fifty Two Week Low4.00
Revenue Growth-5.40%
Shares Short Prior Month16.24M
Average Daily Volume Last 10 Day14.61M
Average Daily Volume In Three Month8.39M
Shares Percent Shares Out4.52%
Gross Margins71.52%
Short Percent Of Float5.15%
Forward Price Earnings0.99
Float Shares299.67M
Fifty Two Week High29.59
Enterprise Value To Ebitda7.53
Fifty Day Average8.13
Two Hundred Day Average19.62
Enterprise Value To Revenue2.84
Continue to Trending Equities. Note that the Bausch Health Companies information on this page should be used as a complementary analysis to other Bausch Health's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try ETF Directory module to find actively traded Exchange Traded Funds (ETF) from around the world.

Complementary Tools for Bausch Stock analysis

When running Bausch Health Companies price analysis, check to measure Bausch Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bausch Health is operating at the current time. Most of Bausch Health's value examination focuses on studying past and present price action to predict the probability of Bausch Health's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Bausch Health's price. Additionally, you may evaluate how the addition of Bausch Health to your portfolios can decrease your overall portfolio volatility.
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Go
Price Transformation
Use Price Transformation models to analyze depth of different equity instruments across global markets
Go
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Go
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Go
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Go
Piotroski F Score
Get Piotroski F Score based on binary analysis strategy of nine different fundamentals
Go
Is Bausch Health's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bausch Health. If investors know Bausch will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bausch Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
1.6
Market Capitalization
2.2 B
Quarterly Revenue Growth YOY
-0.063
Return On Assets
0.0343
Return On Equity
-3.28
The market value of Bausch Health Companies is measured differently than its book value, which is the value of Bausch that is recorded on the company's balance sheet. Investors also form their own opinion of Bausch Health's value that differs from its market value or its book value, called intrinsic value, which is Bausch Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bausch Health's market value can be influenced by many factors that don't directly affect Bausch Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bausch Health's value and its price as these two are different measures arrived at by different means. Investors typically determine Bausch Health value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bausch Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.